2025-10-16 23:34:18
Latest Post
Sprayking Ltd Q2 FY2026 consolidated PAT at Rs. 4.10 crore
Waaree Energies Ltd Q2FY26 consolidated net profit increases to Rs. 842.55 crores
Rajesh Power Services Ltd bags orders worth Rs. 921.89 crore from UGVCL
Novelix Pharmaceuticals Ltd signs Technology Transfer agreement GMBU e.V., Germany for Large-Scale of Astaxanthin
Central Bank of India announces Co-Lending Partnership with Godrej Housing Finance Ltd
Stock Report
Rossari Biotech Ltd Q2 FY2025-26 consolidated PAT increases to Rs. 36.87 crores
Posted On : 2025-10-15 23:47:40( TIMEZONE : IST )
Rossari Biotech Limited has reported Consolidated financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 587.711 crores during the period ended September 30, 2025 as compared to Rs. 544.916 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. 36.876 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. 33.596 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. 6.65 for the period ended September 30, 2025 as compared to Rs. 6.06 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹587.711 crs | ₹544.916 crs |  7.85% |
| Net Profit | ₹36.876 crs | ₹33.596 crs | 9.76% |
| EPS | ₹6.65 | ₹6.06 | 9.74% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs.587.711 crores during the period ended September 30, 2025 as compared to Rs.499.070 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.36.876 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.35.333 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.6.65 for the period ended September 30, 2025 as compared to Rs.6.38 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹587.711 crs | ₹499.070 crs | 17.76% |
| Net Profit | ₹36.876 crs | ₹35.333 crs | 4.37% |
| EPS | ₹6.65 | ₹6.38 | 4.23% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.113.2627 crores during the 6 Months period ended September 30, 2025 as compared to Rs.989.668 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.70.472 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.70.232 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.12.74 for the 6 Months period ended September 30, 2025 as compared to Rs.12.69 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹113.2627 crs | ₹989.668 crs |  -88.56% |
| Net Profit | ₹70.472 crs | ₹70.232 crs | 0.34% |
| EPS | ₹12.74 | ₹12.69 | 0.39% |
Shares of Rossari Biotech Limited was last trading in BSE at Rs. 660.80 as compared to the previous close of Rs. 647.05. The total number of shares traded during the day was 6459 in over 584 trades.
The stock hit an intraday high of Rs. 670.90 and intraday low of 640.25. The net turnover during the day was Rs. 4253827.00.
